NEW YORK (GenomeWeb News) – SAIC-Frederick and Roche Applied Science will collaborate to test Roche's sequence capture and sequencing technologies for use in research projects for the National Cancer Institute, Roche Diagnostics said today.

A contractor for NCI, SAIC-Frederick will use the NimbleGen Sequence Capture technology, along with the Genome Sequencer FLX from Roche's 454 Life Sciences business, to conduct targeted re-sequencing for cancer genomics studies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.